BME:RJFPharmaceuticals
Reig Jofre (BME:RJF) Margin Compression To 1.5% Tests Bullish Earnings Narratives
Laboratorio Reig Jofre (BME:RJF) has just wrapped up FY 2025 with fourth quarter revenue of €94.7m and net income of €3.1m, translating to Basic EPS of €0.04. The trailing 12 month figures show revenue of €336.7m and net income of €5.0m, with Basic EPS of €0.06. Over recent quarters, revenue has ranged from €72.8m to €94.7m, and quarterly net income has moved between a loss of €2.1m and a profit of €3.7m. This sets up a picture where investors are likely to focus on how consistent margins...